Image Source : Indian Pharma Post
Veerhealth Care Ltd has commenced execution of export orders to the United States following successful completion of the USFDA assessment of Form 4003. This marks a pivotal moment in the company’s global expansion strategy.
Key Highlights:
- USFDA approval received on May 16, 2025
- Three full-container-load shipments already dispatched
- Company targets 4–5 monthly shipments to US clients
- Expected monthly export orders: Rs 1.50 crore; annual: Rs 18 crore
- Total export orders secured so far: Rs 3.50 crore
Strategic Expansion:
- Vapi plant upgraded to meet CGMP norms for USFDA compliance
- Factory approved by a major Russian corporate group for oral care exports
- Company anticipates reaching Rs 100 crore revenue with 10% PAT in 2–3 years
Product Focus:
Ayurvedic oral care and personal care products, including vegetarian toothpaste, shampoos, creams, and bath essentials
Sources: ANI News, NDTV Profit, Rediff MoneyWiz, The Week, Equity Bulls
Advertisement
Advertisement